ENSG00000011426 Expression In 33 Tumors
| Ensembl ID |
Gene symbol |
Log2 Foldchange |
Pvaue |
Cancer |
| ENSG00000011426 |
|
2.30 |
1.35e-47 |
KIRC |
| ENSG00000011426 |
|
1.32 |
1.55e-21 |
HNSC |
| ENSG00000011426 |
|
2.03 |
1.70e-14 |
BLCA |
| ENSG00000011426 |
|
3.36 |
6.45e-169 |
BRCA |
| ENSG00000011426 |
|
2.10 |
9.22e-75 |
COAD |
| ENSG00000011426 |
|
1.73 |
1.64e-13 |
READ |
| ENSG00000011426 |
|
4.16 |
5.50e-250 |
LUSC |
| ENSG00000011426 |
|
2.49 |
2.30e-23 |
KIRP |
| ENSG00000011426 |
|
3.63 |
2.40e-70 |
LIHC |
| ENSG00000011426 |
|
2.02 |
2.14e-34 |
STAD |
| ENSG00000011426 |
|
3.11 |
2.09e-67 |
UCEC |
| ENSG00000011426 |
|
2.34 |
3.17e-15 |
ESCA |
| ENSG00000011426 |
|
4.47 |
1.17e-26 |
CHOL |
| ENSG00000011426 |
|
5.79 |
7.58e-34 |
CESC |
| ENSG00000011426 |
|
3.77 |
2.55e-102 |
LUAD |
| Ensembl ID |
Gene symbol |
Disease/phenotype |
Mutation type |
Mutated / Total samples |
Literature |
| Ensembl ID |
Gene symbol |
Cancer |
P-value |
Which worse |
show |
| ENSG00000011426 |
|
SARC |
0.0055 |
high |
|
| ENSG00000011426 |
|
STAD |
0.032 |
low |
|
| ENSG00000011426 |
|
CHOL |
0.046 |
high |
|
| ENSG00000011426 |
|
PAAD |
0.00019 |
high |
|
| ENSG00000011426 |
|
UCEC |
0.00019 |
high |
|
| ENSG00000011426 |
|
THCA |
0.023 |
high |
|
| ENSG00000011426 |
|
LGG |
0.0085 |
high |
|
| ENSG00000011426 |
|
LUSC |
0.047 |
low |
|
| ENSG00000011426 |
|
HNSC |
0.011 |
high |
|
| ENSG00000011426 |
|
PCPG |
0.0015 |
high |
|
| ENSG00000011426 |
|
THYM |
0.00014 |
low |
|
| ENSG00000011426 |
|
BRCA |
0.0084 |
high |
|
| ENSG00000011426 |
|
OV |
0.05 |
high |
|
| ENSG00000011426 |
|
PRAD |
0.01 |
high |
|
| ENSG00000011426 |
|
BLCA |
0.0015 |
high |
|
| ENSG00000011426 |
|
GBM |
0.018 |
high |
|
| ENSG00000011426 |
|
CESC |
0.0013 |
high |
|
| Ensembl ID |
Gene symbol |
Cancer |
CNV type |
-log10(q-value) |
G-score |
average amplitude |
frequency |